This project explores the role of oligodendrocytes in Fragile X. The team will test if improving these cells’ function can restore normal brain activity to treat Fragile X.
Read moreUniversity of Edinburgh, Scotland
Somatosensory Processing as a Therapeutic Target for Fragile X Syndrome

FRAXA-funded researchers in Edinburgh assessed a noninvasive touch test that could be used for clinical trials in Fragile X syndrome.
Read moreEnhancement of NMDA Receptor Signaling for the Treatment of Fragile X Syndrome

FRAXA Research Foundation funded a 2016-2017 Fellowship for Dr. Stephanie Barnes in the University of Edinburgh lab of Dr. Emily Osterweil. With this $90,000 award, the team is investigating NMDA signaling in fragile X syndrome mice.
Read moreDevelopment of the Fragile X Brain: Cellular Processes Regulated by FMRP During Development

With a $120,000 grant from FRAXA Research Foundation over 2 years, Dr. Peter Kind and his team at the University of Edinburgh will study the way FMRP affects and is affected by cortical development.
Read more